Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT00732342 · ClinicalTrials.gov registry record · NA
Contingency Management Treatment Duration
A NA study of Alcohol Abuse, sponsored by UConn Health.
- Completed
- Registry status
- NA
- Development phase
- 310
- Enrollment target
- 5
- Study locations
NCT00732342: Completed NA study of Alcohol Abuse, sponsored by UConn Health.
NCT00732342 is a NA study of Alcohol Abuse that has completed, run by UConn Health. The registered enrollment target is 310 participants, below the 706-participant average among 46 other Alcohol Abuse trials with a reported enrollment target (56% lower). The trial reports 5 study locations across 2 states. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT00732342, a NA study of Alcohol Abuse, has completed, sponsored by UConn Health.
- COMPLETED
- Registry status
- NA
- Development phase
- 310 participants
- Enrollment target
- 5
- Study locations
Study Summary
310 alcohol abusing or dependent patients beginning intensive outpatient day treatment at community-based clinics will be randomly assigned to one of four conditions: (a) standard treatment as usual (ST) at the clinic without contingency management (CM); (b) standard treatment with contingency management for 12 weeks with a 0.5 probability of winning prizes for each negative sample submitted; (c) standard treatment with contingency management for 24 weeks with a 0.34 probability of winning prizes for each negative sample submitted; or (d) standard treatment with contingency management for 24 weeks with a 0.5 probability of winning prizes for each negative sample submitted. We expect that contingency management will decrease alcohol use to a greater extent than non-contingency management treatment, and that availability of contingency management for 24 weeks may result in longer term benefits than 12 week exposure to contingency management. This study will be the first to evaluate the effects of probability of winning prizes on response to contingency management.
Conditions Studied
Interventions
- BEHAVIORAL Contingency Management
Study Locations (5)
Connecticut
- Prospect House - Bridgeport
- Alcohol and Drug Recovery Centers, Inc. - Hartford
- The Hospital of Central Connecticut at New Britain General - New Britain
- Morris Foundation - Waterbury
Massachusetts
- Carlson Recovery Center - Springfield
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 310 participants |
| Start Date | 2008-02 |
| Est. Completion | 2015-05 |
| Phase | NA |
What the finished NCT00732342 record still lists
NCT00732342 is an interventional study that assigns participants to a tested intervention. The registered 310 participants enrollment target is mid-sized for trials with a published cap, below the 706-participant average among 46 other Alcohol Abuse trials with a reported enrollment target (56% lower).
The record links to 1 condition, with Alcohol Abuse appearing as the primary indexed condition, and to 1 intervention - of which Contingency Management is the first listed.
NCT00732342 lists 5 locations in 2 states (Connecticut, Massachusetts).
Frequently Asked Questions
What is clinical trial NCT00732342 about?
NCT00732342 is a clinical study titled "Contingency Management Treatment Duration". 310 alcohol abusing or dependent patients beginning intensive outpatient day treatment at community-based clinics will be randomly assigned to one of four conditions: (a) standard treatment as usual (ST) at the clinic without contingency management (CM); (b) standard treatment with contingency manag...
What is the current status of trial NCT00732342?
This trial is currently completed. It is a NA study. The enrollment target is 310 participants. The study started on 2008-02. Estimated completion is 2015-05.
What conditions does trial NCT00732342 study?
This clinical trial studies the following conditions: Alcohol Abuse.
What interventions are being tested in trial NCT00732342?
The interventions under investigation include: Contingency Management (BEHAVIORAL).
Who is sponsoring clinical trial NCT00732342?
This trial is sponsored by UConn Health, which has 178 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT00732342 being conducted?
This trial has 5 study locations across Connecticut, Massachusetts. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Similar trials for Alcohol Abuse
Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.
Where NCT00732342's enrollment target sits among peer trials
310 16th of 46 higher than 31 of 46 other Alcohol Abuse trials
participants (enrollment target), bucketed by value
Each bar is a band; taller bars hold more other Alcohol Abuse trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.
Source ClinicalTrials.gov registry export · 2026-08-08
-
Personalized Feedback Intervention for Latinx Drinkers With Anxiety
RECRUITING · NA
-
Adaptation and Evaluation of Bright Horizons
RECRUITING · NA
-
Mobile App for Latinx Hazardous Drinkers With Clinical Anxiety
RECRUITING · NA
-
A SMART Evaluation of an Adaptive Web-based AUD Treatment for Service Members and Their Partners
RECRUITING · NA
-
Developing Functional Connectivity-Guided TMS for Alcohol Use Disorder
RECRUITING · NA
-
Safety and Effectiveness of the BrainsWay Deep Transcranial Magnetic Stimulation (Deep TMS) for Treatment of Alcohol Use Disorder (AUD)
RECRUITING · NA
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT03039439 · 310 participants
Molecular and Immunohistochemical Profiling of Tumors in Patients With Parathyroid Tumors
- NCT04178018 · 310 participants · NA
Transvaginal Ultrasound and Photoacoustic Imaging of Ovary
- NCT04878094 · 310 participants · Phase 3
A Study of Intra-operative Imaging in Women With Ovarian Cancer
- NCT05459233 · 310 participants · NA
Valve Hemodynamic Optimization Based on Doppler-Echocardiography vs Catheterization Measurements Following ViV TAVR
Similar registry start date
- NCT05988463 · started 2027-01-01 · Phase 1
Dose-Escalation Study of Artesunate Patients With IPF
- NCT07219706 · started 2026-12-10 · NA
Dietary Fiber and Time Restricted Eating
- NCT02831335 · started 2026-12-01
Technical Development of Multi-Parametric Renocerebral MRI
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia